Menu

Topics

Connect

Comments

Want to discuss? Please read our Commenting Policy first.

‘It’s been tough this third time around’: Matthew Schreindorfer on return of cancer

WATCH ABOVE: Matthew Schreindorfer's journey since being diagnosed with acute lymphoblastic leukemia in 2014.

MONTREAL – It’s a devastating blow, but Matthew Schreindorfer faced the news his cancer was back with the same determined optimism that has characterized his journey so far.

Story continues below advertisement

Schreindorfer first made headlines in 2014 after crowdfunding his way to an experimental cancer treatment in New York, for a rare form of Leukemia.

After a susccessful bone-marrow transplant in Quebec in June of 2015, Schreindorfer was getting ready to celebrate Christmas when he learned the cancer was back.

In between treatments and endless hospital visits, Schreindorfer and his wife Katia Luciano, worked tirelessly in an effort to eventually bring immunotherapy treatments to Quebec.

READ MORE: Matthew Schreindorfer lobbies for better cancer treatment in Quebec

In March, the couple traveled to Maryland so Schreindorfer could take part in his second CAR-T cancer treatment at the government-run National Institute of Health (NIH).

But before the  aggressive treatment began, he was declared cancer-free and sent home to Montreal.

WATCH BELOW: Behind the science of cancer-fighting immunotherapy

Story continues below advertisement

Now, less than one month after Global News caught up with Schreindorfer in Boisbriand, more bad news.

READ MORE: After roller coaster diagnoses, Matthew Schreindorfer is now cancer free

In a Facebook message posted to the “Help Save Matthew Page“, Schreindorfer shared the news  on Wednesday:

“Yep, so I guess I’ll just break it to you: cancer’s back.”

An X-Ray revealed that a dry cough he was experiencing was due to liquid building up in the space between his lungs and rib cage. An other exam confirmed the leukemia was back.

And the news only got worse.

“The plan was to get me back to the NIH as fast as we could, but obviously being out of the picture for three months consequently made my name drop down a bit in their CAR-T clinical trial waiting list.”

Story continues below advertisement

While Schreindorfer admitted to being “a little bit drained physically and emotionally” he’s staying focused on the positive.

“As always, we still have options, and a plan.”

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article